Drawing for SALIVAGENE

USPTO serial 85486085

SALIVAGENE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BROWN, TINA
Law office
TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SALIVAGENE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ursula B. Day

Ursula B. Day LAW FIRM OF URSULA B. DAY708 THIRD AVESuite 1501NEW YORK, NY 10017

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical and biotechnology products for commercial and scientific use, namely, nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; nucleic acid sequences and chemical reagents for medical and veterinary purposes; enzymes for scientific and research purposes; polymerase for scientific and research purposes; reagent buffers for use in the biotechnology field; aqueous and non-aqueous solutions of alcohol and/or salts for industrial purposes; distilled and purified water for industrial purposes; silicates of aluminum, calcium, iron, lead, potassium, sodium; magnetic beads for scientific and research purposes; column materials, namely, particulate chemicals for the purification of biomolecules; reagents and solvents for scientific and research use, for the preparation of assays, purification, lysis, modification or manipulation of cells and for application of marking-, separating-, isolating-, purifying-, multiplying- or analyzing methods on biopolymers; kits, comprising chemical, biochemical and biotechnological reagents needed for Isolation of DNA from DNA samples of a subject; laboratory reagents for use in molecular-biological research and sets of reagents for molecular-biological, clinical or medical laboratory use; restriction enzymes for scientific and research purposes; diagnostic preparations other than for medical or veterinary purposesACTIVE—
005Diagnostic preparations for medical and veterinary use; products for medical and veterinary purposes, namely, medical diagnostic reagents for medical and veterinary purposes; absorbent cotton for medical purposes; cotton swabs for medial purposes; kits comprising products for medical and/or veterinary purposes, namely, kits comprising agents and solvents for stabilizing DNAACTIVE—
009Scientific apparatus, instruments and devices for research- development-or investigatory purposes and laboratory equipment, namely, microscopes, plastic, rubber and elastomer closures for laboratory vessels, residual gas analyzers, flow-based analyzers providing cell and particle analysis, detection, or counting for scientific, laboratory, and general research uses, liquid analyzers, pipette racks, thermometers, test tubes, spectroscopes, incubators, vessels, electric bath heaters, foil elements, namely, circuits for heating or electrical conduction; measuring apparatuses and instruments for producing products for medical and veterinary diagnostic purposes, namely, clinical laboratory analyzers for measuring, testing and analyzing bodily fluids; automated laboratory installations and replacements and accessories therefore, namely, automated laboratory equipment for cutting specimens, automatic fluid composition control machines and instruments, namely, incubators, spectrometers, liquid analyzers, microarrays, mechanical devices, namely, dispensers of preset portions of fluids, solid granules and powder for dosing purposes, all not for medical use; physical, chemical, biochemical, optical and electronic analyzing instruments, namely, photometers and analyzers based on ion-sensitive technology for analyzing chemicals and liquids; laboratory instruments for dosing, in the nature of mechanical dispenser for preset portions for dosing reagents for probes, transferring instruments, namely, pipettes, temperature-monitoring, in the nature of electronic temperature sensors, stirrers for mixing probes, instrument for diluting and separating of fluids, namely, gas mixers for laboratory use, centrifuges, high-pressure pumps for proportioning and testing purposes; instruments for taking probes, namely, pipettes that are controlled by mechanical, optical and pneumatic means; devices for controlling temperature of probes and reagents, namely, temperature sensors, temperature meters not for medical use, temperature transmitters; laboratory centrifuges; one-way articles for use in the laboratory, namely, plastic optical cells for use in spectroscopy, probe supply mini containers, tips for pipettes and injection needle parts for pipette devices, shelves and racks for use in probe distribution-, marking-, and identification; transport devices, namely, carts for probe containers, for container batteries and rack units; instruments for data collection-, processing-, storing-, and output, namely, computer systems comprising the associated application programs on magnetic disks, paper strips, RAMs and floppy disks for application in analytic chemistry in clinical-chemical laboratories; instruments for electronic data processing and control, also those for integration into the analyzing devices, namely, data processors and hardwareACTIVE—
042Scientific and technological services, namely, biomedical research services and technological consulting services in the field of biomedical development; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto in the field of chemistry, medicine, genetics, biology and biochemistry; diagnostic services in the area of DNA-, RNA-, and protein detection and analysis in the fields of science and research related thereto; services in the area of forensics, namely, providing DNA analyses; consultation relating to organizing and equipping medical and chemical laboratoriesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 12, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 4, 2013MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 3, 2013ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 22, 2013ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 5, 2012GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 5, 2012GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 5, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 12, 2012ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 12, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 2, 2012ALIEASSIGNED TO LIE—
Sep 21, 2012FAXXFAX RECEIVED—
Mar 21, 2012GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2012GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 15, 2012DOCKASSIGNED TO EXAMINER—
Dec 9, 2011MPMKNOTICE OF PSEUDO MARK MAILED—
Dec 8, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 6, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance